Cargando…

Infrared spectroscopy analysis determining secondary structure change in albumin by cerium oxide nanoparticles

Cerium oxide (CeO(2)) nanoparticles are expected to have applications in the biomedical field because of their antioxidative properties. Inorganic nanoparticles interact with proteins at the nanoparticle surface and change their conformation when administered; however, the principle underlying this...

Descripción completa

Detalles Bibliográficos
Autores principales: Umezawa, Masakazu, Itano, Ryodai, Sakaguchi, Naoya, Kawasaki, Takayasu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561088/
https://www.ncbi.nlm.nih.gov/pubmed/37818288
http://dx.doi.org/10.3389/ftox.2023.1237819
_version_ 1785117848576720896
author Umezawa, Masakazu
Itano, Ryodai
Sakaguchi, Naoya
Kawasaki, Takayasu
author_facet Umezawa, Masakazu
Itano, Ryodai
Sakaguchi, Naoya
Kawasaki, Takayasu
author_sort Umezawa, Masakazu
collection PubMed
description Cerium oxide (CeO(2)) nanoparticles are expected to have applications in the biomedical field because of their antioxidative properties. Inorganic nanoparticles interact with proteins at the nanoparticle surface and change their conformation when administered; however, the principle underlying this interaction is still unclear. This study aimed to investigate the secondary structural changes occurring in bovine serum albumin (BSA) mixed with CeO(2) nanoparticles having different surface modifications using Fourier transform infrared spectroscopy. CeO(2) nanoparticles (diameter: 240 nm) were synthesized from an aqueous cerium (III) nitrate solution using a homogeneous precipitation method. The surfaces of the nanoparticles were modified by the catechol compounds dopamine and 3,4-dihydroxyhydrocinnamic acid (DHCA). In the presence of these CeO(2) nanoparticles (0.11–0.43 mg/mL), β-sheet formation of BSA (30 mg/mL) was promoted especially on the amine-modified (positively charged) nanoparticles. The local concentration of BSA on the surface of the positively charged nanoparticles may have resulted in structural changes due to electrostatic and other interactions with BSA. Further investigations of the interaction mechanism between nanoparticles and proteins are expected to lead to the safe biomedical applications of inorganic nanoparticles.
format Online
Article
Text
id pubmed-10561088
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105610882023-10-10 Infrared spectroscopy analysis determining secondary structure change in albumin by cerium oxide nanoparticles Umezawa, Masakazu Itano, Ryodai Sakaguchi, Naoya Kawasaki, Takayasu Front Toxicol Toxicology Cerium oxide (CeO(2)) nanoparticles are expected to have applications in the biomedical field because of their antioxidative properties. Inorganic nanoparticles interact with proteins at the nanoparticle surface and change their conformation when administered; however, the principle underlying this interaction is still unclear. This study aimed to investigate the secondary structural changes occurring in bovine serum albumin (BSA) mixed with CeO(2) nanoparticles having different surface modifications using Fourier transform infrared spectroscopy. CeO(2) nanoparticles (diameter: 240 nm) were synthesized from an aqueous cerium (III) nitrate solution using a homogeneous precipitation method. The surfaces of the nanoparticles were modified by the catechol compounds dopamine and 3,4-dihydroxyhydrocinnamic acid (DHCA). In the presence of these CeO(2) nanoparticles (0.11–0.43 mg/mL), β-sheet formation of BSA (30 mg/mL) was promoted especially on the amine-modified (positively charged) nanoparticles. The local concentration of BSA on the surface of the positively charged nanoparticles may have resulted in structural changes due to electrostatic and other interactions with BSA. Further investigations of the interaction mechanism between nanoparticles and proteins are expected to lead to the safe biomedical applications of inorganic nanoparticles. Frontiers Media S.A. 2023-09-25 /pmc/articles/PMC10561088/ /pubmed/37818288 http://dx.doi.org/10.3389/ftox.2023.1237819 Text en Copyright © 2023 Umezawa, Itano, Sakaguchi and Kawasaki. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Toxicology
Umezawa, Masakazu
Itano, Ryodai
Sakaguchi, Naoya
Kawasaki, Takayasu
Infrared spectroscopy analysis determining secondary structure change in albumin by cerium oxide nanoparticles
title Infrared spectroscopy analysis determining secondary structure change in albumin by cerium oxide nanoparticles
title_full Infrared spectroscopy analysis determining secondary structure change in albumin by cerium oxide nanoparticles
title_fullStr Infrared spectroscopy analysis determining secondary structure change in albumin by cerium oxide nanoparticles
title_full_unstemmed Infrared spectroscopy analysis determining secondary structure change in albumin by cerium oxide nanoparticles
title_short Infrared spectroscopy analysis determining secondary structure change in albumin by cerium oxide nanoparticles
title_sort infrared spectroscopy analysis determining secondary structure change in albumin by cerium oxide nanoparticles
topic Toxicology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561088/
https://www.ncbi.nlm.nih.gov/pubmed/37818288
http://dx.doi.org/10.3389/ftox.2023.1237819
work_keys_str_mv AT umezawamasakazu infraredspectroscopyanalysisdeterminingsecondarystructurechangeinalbuminbyceriumoxidenanoparticles
AT itanoryodai infraredspectroscopyanalysisdeterminingsecondarystructurechangeinalbuminbyceriumoxidenanoparticles
AT sakaguchinaoya infraredspectroscopyanalysisdeterminingsecondarystructurechangeinalbuminbyceriumoxidenanoparticles
AT kawasakitakayasu infraredspectroscopyanalysisdeterminingsecondarystructurechangeinalbuminbyceriumoxidenanoparticles